NL-OMON30826已完成不适用
Minimal residual disease (MRD) monitoring in neuroblastoma to improve MRD based risk stratification - MRD monitoring in children with neuroblastoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •- children with high or medium risk neuroblastoma
- •- treated according to dutch-german protocol
排除标准
- •- children with low risk neuroblastoma
- •- children with ganglioneuroma
研究者
相似试验
已完成
Unknown
Survey on Minimal Residual Disease (MRD) Measurement in Multiple MyelomaMultiple MyelomaJPRN-UMIN000052475Sanofi K.K.158
撤回
不适用
' Biomarkers for minimal residual disease in neuro-oncology ': MIRDINO studyNL-OMON46208Academisch Medisch Centrum400
已完成
不适用
Non-invasive MRD Assessment in Multiple MyelomaMyelomaNCT05625971Rajshekhar Chakraborty, MD36
进行中（未招募）
不适用
Eradication of Minimal Residual Disease (MRD) in patients with Chronic Lymphocytic Leukaemia (CLL) with Alemtuzumab: A Phase II Study - UKCLL07Chronica Lymphocytic Leukaemia (CLL)EUCTR2006-000053-22-GBeeds Teaching Hospitals NHS Trust54
已完成
不适用
Prospective evaluation of minimal residual disease in acute myeloid leukemia using TIM-3 as a leukemia markeracute myeloid leukemiaJPRN-UMIN000030977Department of Medicine and Biosystemic Sciences, Kyushu University Graduate School of Medicine50